These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 11531900)
1. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Pascual J; Muñoz R; Leira R Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900 [TBL] [Abstract][Full Text] [Related]
3. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Pascual J; Fité B; López-Gil A Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301 [TBL] [Abstract][Full Text] [Related]
4. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients]. Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773 [TBL] [Abstract][Full Text] [Related]
5. Patient preference for triptan formulations: a prospective study with zolmitriptan. Dowson A; Bundy M; Salt R; Kilminster S Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519 [TBL] [Abstract][Full Text] [Related]
6. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L; Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197 [TBL] [Abstract][Full Text] [Related]
7. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Gallagher RM; Dennish G; Spierings EL; Chitra R Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911 [TBL] [Abstract][Full Text] [Related]
8. Clinical applications of new therapeutic deliveries in migraine. Dahlöf C Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656 [TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. Gruffyd-Jones K; Kies B; Middleton A; Mulder LJ; Røsjø Ø; Millson DS Eur J Neurol; 2001 May; 8(3):237-45. PubMed ID: 11328332 [TBL] [Abstract][Full Text] [Related]
10. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. MacGregor EA; Brandes J; Eikermann A Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754 [TBL] [Abstract][Full Text] [Related]
11. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Mathew NT; Kailasam J; Gentry P; Chernyshev O Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042 [TBL] [Abstract][Full Text] [Related]
12. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine. Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K; Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269 [TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan: differences from sumatriptan. Goadsby PJ; Boes CJ Curr Med Res Opin; 2001; 17 Suppl 1():s46-50. PubMed ID: 12463277 [TBL] [Abstract][Full Text] [Related]
14. Comparative aspects of triptans in treating migraine. Adelman JU; Lewit EJ Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444 [TBL] [Abstract][Full Text] [Related]
16. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet. Dowson AJ; Almqvist P Curr Med Res Opin; 2005; 21 Suppl 3():S13-7. PubMed ID: 16083519 [TBL] [Abstract][Full Text] [Related]
17. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study]. Stöckli HR; Sword A Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591 [TBL] [Abstract][Full Text] [Related]
18. Newer formulations of the triptans: advances in migraine management. Gladstone JP; Gawel M Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731 [TBL] [Abstract][Full Text] [Related]